A rally in biotech stocks has raised hopes of a turnaround from the sector’s worst run this century, as drug developers suffered from rising interest rates and a backlash to pandemic-era euphoria.
生物科技股的反弹带来了该行业扭转本世纪最糟糕走势的希望，此前药物开发商受到了利率上升和对疫情时期兴奋情绪反弹的影响。
您已阅读4%（254字），剩余96%（5514字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。